IHK Labelling 2013

Embed Size (px)

Citation preview

  • 7/24/2019 IHK Labelling 2013

    1/50

    Labelling_Conjugated

  • 7/24/2019 IHK Labelling 2013

    2/50

    Monoclonal & Polyclonal

    Polyclonal Monoclonal

    Contains many antibodies

    recognizing many

    detedminants on an antigen

    Contains a singleantibody

    recognizing only a single

    determination

    Various classesof

    antibodies are present(IgG,IgM,and so on)

    Single classof antibody

    produced

    Can make a specific antibody using only

    a igly purified antigen

    Can make a specific antibody using an

    impure antigen

    !eproducibility andstandardization difficult

    "igly reproducible

  • 7/24/2019 IHK Labelling 2013

    3/50

    Antibody labelling methods:

    1. Immunoenzyme method: An enzyme is used as the label.Peroxidase, alkalin phosfatase, glucose oxidaseChromogen staining chemical! must be used

    ". Immunofluorescence method: A fluorochrome is used as

    the label.A#CA, $luorescein, $I%C, &odomine, %&I%C, %exas &ed.$luorescence microscope 'ith appropriate filter or confocallaser scanning microscope must be used to (isualize.

    ). Immunogold method: colloidal gold particles are used asthe label.*sually used in electron microscopy.

  • 7/24/2019 IHK Labelling 2013

    4/50

    Immunolabelling methods:

    1. +irect method: %he antigen directly binds to its specificlabelled antibody primary antibody!

    $ast to get the resultsabeling intensity is lo'

    *sed for kidney or skin biopsies.

  • 7/24/2019 IHK Labelling 2013

    5/50

    +irect method

  • 7/24/2019 IHK Labelling 2013

    6/50

    Immunolabelling methods:

    ". Indirect method:Primary antibody is unlabelled. Asecondary antibody 'hich is labeled! is used.

    -econdary antibody must be raised against the immunoglobulin of the

    species 'hich the primary antibody is made in.

    etting results takes longer#ore sensiti(e#ore economic

  • 7/24/2019 IHK Labelling 2013

    7/50

    Indirect method

  • 7/24/2019 IHK Labelling 2013

    8/50

    $luorescence #ethod

    %exas &ed,

    &odamin,

    Cy)

    A#CA

    $I%C,

    Cy"

  • 7/24/2019 IHK Labelling 2013

    9/50

    Immunolabelling methods:

    ). *nlabelled antibody methods:/nzym0antienzym methodPeroxidase antiperoxidase PAP!Alkaline phosphatase 0 anti0Alkaline phosphatase APAAP!

    #ost sensiti(e results2idely usedApplied on paraffin, cryostat sections or on smears.

  • 7/24/2019 IHK Labelling 2013

    10/50

    Peroxidase

    antiperoxidasePAP!

    Alkaline phosphatase 0

    anti0Alkalinephosphatase APAAP!

  • 7/24/2019 IHK Labelling 2013

    11/50

    Immunolabelling methods:

    3. A(idin04iotin method:*ses the high affinity of A(idin glycoprotein! for biotin

    (itamin!.A complex of a(idin0biotin0enzym peroksidaz! is

    necessary.

    -treptoa(idin can be used instead of a(idin.

    %he secondary antibody is labelled 'ith biotin 'hichinturn binds to a(idin in the a(idin0biotin0enzym complex.

    5ery high sensiti(ity*sed in research more than routine studies. It is longer andmore expensi(e.

  • 7/24/2019 IHK Labelling 2013

    12/50

  • 7/24/2019 IHK Labelling 2013

    13/50

    In order to (isualize the enzymes labelling the antibodies'ith light microscope, enzyme substrate reactions, 'hich

    con(ert colorless chromogens into (isible colored end0products, is used.:

    Peroxidase0 hydrogen peroxide0 diaminobenzidine+A4!:

    )0amino060ethylcarbazole A/C!:

    70chloro010naphthol C8!: 9;* #A5

    to detect:

    Proteins, carbohidrates, nucleic acids, lipits

    %ypes of the secreting cells

    #embrane antigens

    -tructural antigens 'ithin the cytoplasm Antigen localised in the nucleus

    Immunohistochemistry is fre=uently used both inexperimental and diagnostical studies

    ight, flouresans, confocal laser scanning or electronmicroscope is used in order to (isualize the labeledantibody0antigen complex.

  • 7/24/2019 IHK Labelling 2013

    22/50

    %he aim of the immunohistochemistry

    to perform most specific immunohistochemicalstaining?

    by cousing least damage on the cell or tissue,

    by using least amount of antibody, in shortest time,

    'ith least backgroung staining.

  • 7/24/2019 IHK Labelling 2013

    23/50

    Immunohistochemistry protocol 01

    4efore incubation 'ith antibody: +eparaffinization.

    &emo(ing the fixati(e: 'ashing in buffer solutionsphosphate buffer, %ris0@Cl buffer, @/P/- buffer, etc!

    8eutralization of the endogeneus peroxidase 4locking: co(ering the non0immunological sticky

    sites on tissues bo(ine serum albumine, non0immune normal serum, gelatine, milk!

    4locking the surface tension: %'een ", %riton B01,

    8aCl!

  • 7/24/2019 IHK Labelling 2013

    24/50

    %issue Preparation

    $ixation: Immersion or perfusion fixation 8eutral formaline

    Paraformaldehyde

    Paraformaldehyde (e picric acid 4ouins solution!

    -ectioning:

    #icrotome: paraffin blocks

    Cryostat: frozen tissue

    5ibratome: fixed hard tissue

    -ections on a slide PAP Pen! $loating sections

  • 7/24/2019 IHK Labelling 2013

    25/50

    Incubation:Primary antibody: *sed in a solution at different dilutions 'iththe blocking agent. %he incubation time changes according tothe properties of the antigen or antibody as 'ell as dependingon the temperature.

    -econdary antibody: #ust be raised in the species otherthan the species of 'hich the cells or tissues are taken orthe primary antibody is raised. It should specificallyrecognize the immunoglobuline of the species in 'hich theprimary antibody is raised.

    abelling: Immunoenzyme, immunoflourescence, immunogold

    #icroscopical analyses

    Immunohistochemistry protocol 0"

  • 7/24/2019 IHK Labelling 2013

    26/50

    +etermining the -ecretory

    Contents of the8euroendocrine 8eurones

  • 7/24/2019 IHK Labelling 2013

    27/50

    %he use of the Immunohistochemistry:

    Intercellular antigens, for instance: immunoglobulines ofthe kidney glomerular basal membrane

    Cell surface antigens, tissue antigen for diagnosingautoimmune diseases

    Protein hormones in histopathological diagnosis -oluble antigens of the cell +iagnosis of the endocrine tumors -mall amounts of peptides in endocrine or neuroendocrine

    cells Immunodeposits %umoral markers %umor typing

  • 7/24/2019 IHK Labelling 2013

    28/50

    The basic p"inciple of

    i!!noflo"escence To se a flo"escent co!pond -sally

    flo"escein. to detect the binding of antigen and

    antibody

    The Ab is labelled 'ith the flo"escent co!pond

    /nde" a flo"escence !ic"oscope0 flo"escein

    appea"s b"ight g"een 'he"eve" the binding occ"s

  • 7/24/2019 IHK Labelling 2013

    29/50

    /sing the flo"escence !ic"oscope

    Select the co""ect filte" bloc) fo" the

    flo"escent co!pond

    Flo"escence fades 1ic)ly nde" /# light2t"y to li!it the ti!e of expos"e to /# as

    !ch as possible

    /se high speed fil!s fo" photog"aphy

  • 7/24/2019 IHK Labelling 2013

    30/50

    Di"ect *!!noflo"escence

    The ai! is to identify the p"esence and

    location of an antigen by the se of a

    flo"escent labelled specific antibody

  • 7/24/2019 IHK Labelling 2013

    31/50

    Medical applications of di"ect *F

    Renal diseases fo" evidence of i!!ne

    deposition

    S)in diseases fo" evidence of i!!nedeposition

    Detection of specific antigens0 especially

    those of infective o"ganis!s

  • 7/24/2019 IHK Labelling 2013

    32/50

    Application in "enal diseases

    *g+

  • 7/24/2019 IHK Labelling 2013

    33/50

    A section of )idney is placed on a slide2 a

    flo"escein3labeled antigloblin -specific fo" *g+0

    in this case. is added0 then "insed a'ay

    The p"esence of flo"escence in the glo!e"li

    indicates that *g+ 'as deposited p"io" to the biopsy

    *g+ is deposited in g"anla" cl!ps along the

    capilla"y 'alls0 enabling a diagnosis of!e!b"anos glo!e"loneph"itis in this case

  • 7/24/2019 IHK Labelling 2013

    34/50

    ,he!il!inescent labels

    Advantages

    Size

    Sensitivity

    Disadvantages

    %a"d'a"e

  • 7/24/2019 IHK Labelling 2013

    35/50

    Doble labelling

  • 7/24/2019 IHK Labelling 2013

    36/50

    *ndi"ect *!!noflo"escence

  • 7/24/2019 IHK Labelling 2013

    37/50

    *ndi"ect *!!noflo"escence

    The ai! is to identify the p"esence of

    antigen specific antibodies in se"!4 The

    !ethod is also be sed to co!pa"econcent"ation of the antibodies in se"a4

  • 7/24/2019 IHK Labelling 2013

    38/50

    *ndi"ect *!!noflo"escence

    A )no'n antigen is placed on a slide2 the

    patient5s se"! is added0 then "insed a'ay4

    A flo"escein3labeled antigloblin is added0

    then "insed a'ay4

    The p"esence of flo"escence ove" the

    antigen indicates the p"esence of antibodiesto this antigen in the patient4

  • 7/24/2019 IHK Labelling 2013

    39/50

    Diagnosis of (acte"ial Diseases

    ,lost"idial diseases -di"ect.

    Brucella canis-indi"ect.

    Afipia catei0 cat sc"atch disease -indi"ect.

    Borrelia burgdorferi-indi"ect.

    Coxiella burnetii0 6 Feve" -indi"ect.

    Rickettsia rickettsiae0 Roc)y Montain

    Spotted Feve" -indi"ect.

  • 7/24/2019 IHK Labelling 2013

    40/50

    Diagnosis of #i"al Diseases

    "abies vi"s -di"ect.

    bovine i!!nodeficiency3li)e vi"s -indi"ect.

    canine co"onavi"s -indi"ect.

    canine diste!pe" -indi"ect.

    feline infectios pe"itonitis -co"ona3. vi"s -di"ect.

    po"cine "espi"ato"y and "ep"odctive synd"o!e-indi"ect.

  • 7/24/2019 IHK Labelling 2013

    41/50

    Diagnosis of P"otozoal Diseases

    (abesia species -indi"ect.

    h"lichia species -indi"ect.

    Toxoplas!a gondii -indi"ect.

    T"ypanoso!a c"zi -indi"ect.

    ,"yptospo"idia7+ia"dia -di"ect.

    ncephalitozoon cnicli -indi"ect.

    8eospo"! canin! -di"ect0 indi"ect.

  • 7/24/2019 IHK Labelling 2013

    42/50

    So!e exa!ples

    *ndi"ect *!!noflo"escence

  • 7/24/2019 IHK Labelling 2013

    43/50

    Indirect #luorescent $ntibody %est for

    $ntibodies to Toxoplasma gondii

    Toxoplasmao"ganis!s a"e )illed and placed on the slide2

    the patient9s se"! is added0 then 'ashed a'ay4

    A flo"escein3labeled antigloblin is added0 then 'ashed

    a'ay4

    The p"esence of the g"een flo"escence otlining the T.

    gondii o"ganis!s indicates the p"esence of antibodies in

    the patient5s se"!4

  • 7/24/2019 IHK Labelling 2013

    44/50

    *!!ne3Mediated Diso"de"s

    antinclea" antibody -A8A. test -fo"

    diagnosis of syste!ic lps e"ythe!atoss.

    Di"ect flo"escent antibody test fo"deposition of Abs in tisses0 e4g4 )idney0

    s)in

  • 7/24/2019 IHK Labelling 2013

    45/50

    Indirect #luorescent $ntibody %est

    for $ntinuclear $ntibodies ,ells f"o! a clt"ed cell line a"e placed on a

    slide2 the patient5s se"! is added0 then "insed

    a'ay4 A flo"escein3labeled antigloblin is added0 then

    "insed a'ay4

    The p"esence of flo"escence in the ncles ofthese cells indicates the p"esence of antibodies to

    nclea" antigens in the patient4

  • 7/24/2019 IHK Labelling 2013

    46/50

    T%A8:S

  • 7/24/2019 IHK Labelling 2013

    47/50

    $*SA

    The $*SA techni1e is sed 'idely to

    detect and 1antitate o"ganis!s and7o" thei"

    p"odcts in foods0 and synopses of so!e ofthese applications a"e p"esented belo'4 Fo"

    !o"e details0 the cited "efe"ences shold be

    conslted4

  • 7/24/2019 IHK Labelling 2013

    48/50

    nzy!e3lin)ed i!!noso"bent assay

    Mic"otite" 'ell

    E E E E E

    Speci!en ;nd antibody

    E

    Sbst"ate

    S P

  • 7/24/2019 IHK Labelling 2013

    49/50

    $*SA -va"iation

  • 7/24/2019 IHK Labelling 2013

    50/50

    $*SA -va"iation ;.

    Mic"otite" 'ell

    Speci!en $abeled antibody

    E

    E E E E

    EEE